Merrimack Pharmaceuticals competitorsClear all

Merrimack Pharmaceuticals's top competitors include Stingray Therapeutics, Northwest Biotherapeutics, Karyopharm Therapeutics and AVEO Pharmaceuticals.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Stingray Therapeutics
Stingray Therapeutics
Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer.
Northwest Biotherapeutics
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
AVEO Pharmaceuticals
AVEO Pharmaceuticals
AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.
Founding Date
Founding Date
2000
Founding Date
2018
Founding Date
1998
Founding Date
2008
Founding Date
2001
Type
Type
Public
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Houston, US HQ
Locations
Bethesda, US HQ
Locations
Newton, US HQ
München, DE
Tel Aviv Yafo, IL
Locations
Cambridge, US HQ
Boston, US
Employees
Employees
2763% decrease
Employees
5
Employees
1721% increase
Employees
4605% increase
Employees
1912% increase
Valuation ($)
Valuation ($)
96.1 m
Valuation ($)
N/A
Valuation ($)
1.2 b
Valuation ($)
N/A
Valuation ($)
245.2 m
Twitter followers
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
2.4 k
Twitter followers
N/A
Twitter followers
920
Alexa Website Rank
Alexa Website Rank
221397
Alexa Website Rank
N/A
Alexa Website Rank
189256
Alexa Website Rank
351923
Alexa Website Rank
280779
Employee Rating
Employee Rating
3
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2.4m (FY, 2019)
Revenue (est.)
$108.1m (FY, 2020)
Revenue (est.)
$28.8m (FY, 2019)
Net income
Net income
($17.3m) (FY, 2019)
Net income
N/A
Net income
($20.3m) (FY, 2019)
Net income
($196.3m) (FY, 2020)
Net income
$9.4m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 79.4m
Total funding raised
N/A
Total funding raised
$ 135.9m
Total funding raised
$ 248.7m
Total funding raised
$ 224m
For sources of this data, please see the company profile

View company profiles

Stingray Therapeutics
HQ
Houston, US
Employees
5

Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer.

View company
Northwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

View company
Karyopharm Therapeutics
HQ
Newton, US

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

View company
AVEO Pharmaceuticals
HQ
Cambridge, US
Employees
19↑ 12% increase

AVEO is a biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.

View company